Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 12, 2008, Pages 3225-3231

  Kamisoyama, Hiroshi ^a   Honda, Kazuhisa ^a   Tominaga, Yuji ^b   Yokota, Shinichi ^b   Hasegawa, Shin ^a  

^a KOBE UNIVERSITY   (Japan)

^b KANEKA CORPORATION   (Japan)

Author keywords

Acetyl coenzyme A carboxylase (ACC); Acyl coenzyme A dehydrogenase (ACD); Cardiovascular disease; Fatty acid synthase (FAS); Insulin

Indexed keywords

ACIDS; CATALYSTS; ECOLOGY; ENZYME ACTIVITY; FATTY ACIDS; HORMONES; INSULIN; NUTRITION; PROTEINS; RATS;

ABDOMINAL ADIPOSES; ACETYL-COENZYME A CARBOXYLASE (ACC); ACYL-COENZYME A DEHYDROGENASE (ACD); CARDIOVASCULAR DISEASE; ENZYMATIC ACTIVITIES; FATTY ACID SYNTHASE (FAS); FLAVONOID; FLAVONOIDS; FUNCTIONAL FOODS; OXIDATIVE PATHWAYS; PLASMA TRIGLYCERIDES; SYNTHETIC PATHWAYS;

ENZYMES;

ACETYL COENZYME A CARBOXYLASE; ANTIOBESITY AGENT; FATTY ACID; FATTY ACID SYNTHASE; FLAVONOID; TRIACYLGLYCEROL; VEGETABLE OIL;

ABDOMEN; ADIPOSE TISSUE; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIET; DRUG ANTAGONISM; DRUG EFFECT; EATING; GLYCYRRHIZA; LIVER; MALE; METABOLISM; OBESITY; OXIDATION REDUCTION REACTION; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ABDOMEN; ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIET; EATING; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; FLAVONOIDS; GLYCYRRHIZA; LIVER; MALE; OBESITY; OXIDATION-REDUCTION; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

GLYCYRRHIZA; GLYCYRRHIZA GLABRA; RATTUS;

EID: 58149092376     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80469     Document Type: Article

References (37)

1. Després, J. P., and Lemieux, I., Abdominal obesity and metabolic syndrome. Nature, 444, 881-887 (2006).
2. Goodpaster, B. H., Krishnaswami, S., Harris, T. B., Katsiaras, A., Kritchevsky, S. B., Simonsick, E. M., Nevitt, M., Holvoet, P., and Newman, A. B., Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med., 165, 777-783 (2005).
3. Hafidh, S., Senkottaiyan, N., Villarreal, D., and Alpert, M. A., Management of the metabolic syndrome. Am. J. Med. Sci., 330, 343-351 (2005).
4. Peluso, M. R., Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp. Biol. Med., 231, 1287-1299 (2006).
5. Murase, T., Nagasawa, A., Suzuki, J., Hase, T., and Tokimitsu, I., Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int. J. Obes., 26, 1459-1464 (2002).
6. Tsuda, T., Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J. Agric. Food Chem., 56, 642-646 (2008).
7. Mitscher, L. A., Drake, S., Gollapudi, S. R., Harris, J. A., and Shankel, D. M., Isolation and identification of higher plant agents active in antimutagenic assay systems: Glycyrrizia glabra. Basic Life Sci., 39, 153-165 (1986).
8. Zhou, S., Koh, H.-L., Gao, Y., Gong, Z., and Lee, E. J. D., Herbal bioactivation: the good, the bad and the ugly. Life Sci., 74, 935-968 (2004).
9. Nakagawa, K., Kishida, H., Arai, N., Nishiyama, T., and Mae, T., Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-Ay mice. Biol. Pharm. Bull., 27, 1775-1778 (2004).
10. Aoki, F., Honda, S., Kishida, H., Kitano, M., Arai, N., Tanaka, H., Yokota, S., Nakagawa, K., Asakura, T., Nakai, Y., and Mae, T., Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci. Biotechnol. Biochem., 71, 206-214 (2007).
11. Mae, T., Kishida, H., Nishiyama, T., Tsukagawa, M., Konishi, E., Kuroda, M., Mimaki, Y., Sashida, Y., Takahashi, K., Kawada, T., Nakagawa, K., and Kitahara, M., A licorice ethanolic extract with peroxisome proliferator- activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J. Nutr., 133, 3369-3377 (2003).
12. Tominaga, Y., Mae, T., Kitano, M., Sakamoto, Y., Ikematsu, H., and Nakagawa, K., Licorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects. J. Health Sci., 52, 672-683 (2006).
13. den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., and Romijn, J. A., Hepatic steatosis: a mediator of the metabolic syndrome: lessons from animal models. Arterioscler. Thromb. Vasc. Biol., 24, 644-649 (2004).
14. Qureshi, K., and Abrams, G. A., Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol., 13, 3540-3553 (2007).
15. Chan, D. C., Watts, G. F., Ng, T. W. K., Hua, J., Song, S., and Barrett, P. H. R., Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Diabetes Obes. Metab., 8, 698-702 (2006).
16. Duval, C., Müller, M., and Kersten, S., PPARα and dyslipidemia. Biochim. Biophys. Acta, 1771, 961-971 (2007).
17. Iritani, N., Nutritional and hormonal regulation of lipogenic-enzyme gene expression in rat liver. Eur. J. Biochem., 205, 433-442 (1992).
18. Lawrence, J. W., Li, Y., Chen, S., DeLuca, J. G., Berger, J. P., Umbenhauer, D. R., Moller, D. E., and Zhou, G., Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR)α. J. Biol. Chem., 276, 31521-31527 (2001).
19. König, B., and Eder, K., Differential action of 13-HPODE on PPARα downstream genes in rat Fao and human HepG2 hepatoma cell lines. J. Nutr. Biochem., 17, 410-418 (2006).
20. Farese, R. V., Jr., Biglieri, E. G., Shackleton, C. H., Irony, I., and Gomez-Fontes, R., Licorice-induced hypermineralocorticoidism. N. Engl. J. Med., 325, 1223-1227 (1991).
21. Ferrari, P., Sansonnens, A., Dick, B., and Frey, F. J., In vivo 11β-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension, 38, 1330-1336 (2001).
22. Nedergaard, J., and Cannon, B., Preparation and properties of mitochondria from different sources. Methods Enzymol., 55, 3-28 (1979).
23. Nepokroeff, C. M., Lakshmanan, M. R., and Porter, J. W., Fatty acid synthase from rat liver. Methods Enzymol., 35, 37-44 (1975).
24. 2+. Clin. Chem., 22, 1812-1816 (1976).
25. Bartlett, G. R., Phosphorus assay in column chromatography. J. Biol. Chem., 234, 466-468 (1959).
26. Nakanishi, S., and Numa, S., Purification of rat liver acetyl coenzyme A carboxylase and immunochemical studies on its synthesis and degradation. Eur. J. Biochem., 16, 161-173 (1970).
27. Mason, K. E., Stofan, D. A., and Szweda, L. I., Inhibition of very long chain acyl-CoA dehydrogenase during cardiac ischemia. Arch. Biochem. Biophys., 437, 138-143 (2005).
28. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
29. Dentin, R., Girard, J., and Postic, C., Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie, 87, 81-86 (2005).
30. Steineger, H. H., Sørensen, H. N., Tugwood, J. D., Skrede, S., Spydevold, Ø., and Gautvik, K. M., Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells: hormonal modulation of fatty-acid-induced transcription. Eur. J. Biochem., 225, 967-974 (1994).
31. Shimano, H., Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog. Lipid Res., 40, 439-452 (2001).
32. Mandard, S., Müller, M., and Kersten, S., Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci., 61, 393-416 (2004).
33. Rosen, E. D., and Spiegelman, B. M., Adipocytes as regulators of energy balance and glucose homeostasis. Nature, 444, 847-853 (2006).
34. Okuno, A., Tamemoto, H., Tobe, K., Ueki, K., Mori, Y., Iwamoto, K., Umesono, K., Akanuma, Y., Fujiwara, T., Horikoshi, H., Yazaki, Y., and Kadowaki, T., Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest., 101, 1354-1361 (1998).
35. Morin, C. L., Gayles, E. C., Podolin, D. A., Wei, Y., Xu, M., and Pagliassotti, M. J., Adipose tissue-derived tumor necrosis factor activity correlates with fat cell size but not insulin action in aging rats. Endocrinology, 139, 4998-5005 (1998).
36. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., and Lazar, M. A., The hormone resistin links obesity to diabetes. Nature, 409, 307-312 (2001).
37. Ronti, T., Lupattelli, G., and Mannarino, E., The endocrine function of adipose tissue: an update. Clin. Endocrinol., 64, 355-365 (2006).